Neurofeedback is the Best Available First-Line Treatment for ADHD: What is the Evidence for this Claim?
Attention Deficit/Hyperactivity Disorder (ADHD) is a chronic syndrome characterized by deficits in executive functions and attentional processes. Persons diagnosed with ADHD have significant deficits in self-regulation evidenced by difficulty staying focused, controlling impulsive behaviors, and for many, restraining hyperactive motor activity. These symptoms typically create problems in academic, social, and familial contexts as well as in the planning and organization skills needed for daily functioning. Additionally, comorbid syndromes that can mimic the symptoms of ADHD and confound differential diagnosis are commonly present (e.g., anxiety, depression, learning disorders).
ADHD is the most frequently diagnosed pediatric disorder with 11% of American school-aged children (and nearly 20% of teenage boys) having been medically diagnosed with ADHD according to the latest report from the Centers for Disease Control (Schwarz & Cohen, 2013). Stimulant medication (SM) and behavior therapy (BT) are the two most widely accepted treatments for ADHD, with approximately 70% of those diagnosed prescribed medication (Schwarz, 2013). Although both interventions are considered to meet the highest standards for the evidence-based treatment of ADHD, and have been recognized as such by the American Academy of Child and Adolescent Psychiatry (AACAP) and Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD), the leading ADHD advocacy group, the actual evidence is that these treatments fail to result in sustained benefit for the vast majority of children who receive them and, therefore, do not warrant being the first option for treating ADHD.
The article reviews the evidence for making neurofeedback the first line treatment for ADHD.
American Academy of Child and Adolescent Psychiatry (2011). ADHD: Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics, 128(5), 2011–2654. http://dx.doi.org/10.1542/peds.2011-2654
Arnold, L. E., Arns, M., Conners, K., deBeus, R., Hirshberg, L., & Monastra, V. (2013). A proposed multisite double-blind randomized clinical trial of neurofeedback for ADHD: Need, rationale, and strategy. Journal of Attention Disorders, 17, 420–436. http://dx.doi.org/10.1177/1087054713482580
Arns, M., de Ridder, S., Strehl, U., Breteler, M., & Coenen, A. (2009). Efficacy of neurofeedback treatment in ADHD: The effects on inattention, impulsivity and hyperactivity: A meta-analysis. Clinical EEG and Neuroscience, 40(3), 180–189. http://dx.doi.org/10.1177/155005940904000311
Arns, M., Heinrich, H., & Strehl, U. (2014). Evaluation of neurofeedback in ADHD: The long and winding road. Biological Psychology, 95, 108–115. http://dx.doi.org/10.1016/j.biopsycho.2013.11.013
Bakhshayesh, A. R., Hansch, S., Wyschkon, A., Rezai, M. J., & Esser, G. (2011). Neurofeedback in ADHD: A single-blind randomized controlled trial. European Child & Adolescent Psychiatry, 20, 481–491. http://dx.doi.org/10.1007/s00787-011-0208-y
Cannon, R. L. (in press). Parietal foci for Attention Deficit/Hyperactivity Disorder: Targets for LORETA neurofeedback with outcomes. Biofeedback Magazine: Special issue on QEEG and Treatment Approaches for ADHD, June 2014.
Cannon, R. L., Baldwin, D., Diloreto, D., Phillips, S., Shaw, T. L., & Levy, J. J. (2014). LORETA neurofeedback in the precuneus: Operant conditioning in basic mechanisms of self-regulation. Clinical EEG and Neuroscience, http://dx.doi.org/10.1177/1550059413512796
Carmody, D. P., Radvanski, D. C., Wadhwani, S., Sabo, J. J., & Vergara, L. (2001). EEG biofeedback training and attention‐deficit/hyperactivity disorder in an elementary school setting. Journal of Neurotherapy, 4, 5–27. http://dx.doi.org/10.1300/j184v04n03_02
deBeus, R. (2006). Progress in efficacy studies of EEG biofeedback for ADHD. Paper presented at the meeting of the American Psychiatric Association, Toronto, Canada.
deBeus, R., & Kaiser, D. A. (2011). Neurofeedback with children with attention-deficit hyperactivity disorder: A randomized double-blind placebo-controlled study. In R. Coben & J. R. Evans (Eds.), Neurofeedback and neuromodulation techniques and applications (pp. 127–152). London, England: Academic Press. http://dx.doi.org/10.1016/b978-0-12-382235-2.00005-6
Drechsler, R., Straub, M., Doehnert, M., Heinrich, H., Steinhausen, H., & Brandeis, D. C. (2007). Controlled evaluation of a neurofeedback training of slow cortical potentials in children with attention deficit/hyperactivity disorder. Behavioral and Brain Functions, 3, 35. http://dx.doi.org/10.1186/1744-9081-3-35
Duric, N. S., Assmus, J., Gundersen, D. I., & Elgen, I. B. (2012). Neurofeedback for the treatment of children and adolescents with ADHD: A randomized and controlled clinical trial using parental reports. BMC Psychiatry, 12, 107. http://dx.doi.org/10.1186/1471-244X-12-107
Fuchs, T., Birbaumer, N., Lutzenberger, W., Gruzelier, J. H., & Kaiser, J. (2003). Neurofeedback treatment for attention-deficit/hyperactivity disorder in children: A comparison with methylphenidate. Applied Psychophysiology and Biofeedback, 28(1), 1–12.
Gani, C., Birbaumer, N., & Strehl, U. (2008). Long term effects after feedback of slow cortical potentials and of theta-beta-amplitudes in children with attention-deficit/hyperactivity disorder (ADHD). International Journal of Bioelectromagnetism, 10(4), 209–232.
Gevensleben, H., Holl, B., Albrecht, B., Vogel, C., Schlamp, D, Kratz, O., … Heinrich, H. (2009a). Is neurofeedback an efficacious treatment for ADHD? A randomized controlled clinical trial. Journal of Child Psychology and Psychiatry, 50(7), 780–789. http://dx.doi.org/10.1111/j.1469-7610.2008.02033.x
Gevensleben, H., Holl, B., Albrecht, B., Schlamp, D., Kratz, O., Studer, P., … Heinrich, H. (2009b). Distinct EEG effects related to neurofeedback training in children with ADHD: A randomized controlled trial. International Journal of Psychophysiology, 74, 149–157. http://dx.doi.org/10.1016/j.ijpsycho.2009.08.005
Gevensleben, H., Holl, B., Albrecht, B., Schlamp, D., Kratz, O., Studer, P., & Heinrich H. (2010). Neurofeedback training in children with ADHD: 6-Month follow-up of a randomized controlled trial. European Child & Adolescent Psychiatry, 19, 715–724. http://dx.doi.org/10.1007/s00787-010-0109-5
Graham, J., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M, Dittman, R. W., … Taylor, E. (2011). European Guidelines Group: European guidelines on managing adverse effects of medication for ADHD. European Child and Adolescent Psychiatry, 20(1), 17–37. http://dx.doi.org/10.1007/s00787-010-0140-6
Greenhill, L., Kollins, S., Abikoff, H., McCraken, J., Riddle, M., Swanson, J., … Cooper, T. (2006). Efficacy and safety of immediate release methylphenidate treatment for preschoolers with ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 45, 1284–1293. http://dx.doi.org/10.1097/01.chi.0000235077.32661.61
Hammond, D. C. (2011). What is neurofeedback: An update. Journal of Neurotherapy, 15, 305–336. http://dx.doi.org/10.1080/10874208.2011.623090
Heinrich, H., Gevensleben, H., Freisleder, F. J., Moll, G. H., & Rothenberger, A. (2004). Training of slow cortical potentials in attention-deficit/hyperactivity disorder: Evidence for positive behavioral and neurophysiological effects. Biological Psychiatry, 55(7), 772–775. http://dx.doi.org/10.1016/j.biopsych.2003.11.013
Hodgson, K., Hutchinson, A. D., & Denson, L. (2012). Nonpharmacological treatments for ADHD: A meta-analytic review. Journal of Attention Disorders, 18(4), 275–82. http://dx.doi.org/10.1177/1087054712444732
Holtmann, M., Grasmann, D., Cionek-Szpak, E., Hager, V., Panzer, N., Beyer, A., & Stadler, C. (2009). Specific effects of neurofeedback on impulsivity in ADHD. Kindheit und Entwicklung, 18, 95–104.
Insel, T. R. (2009). Disruptive insights in psychiatry: Transforming a clinical discipline. Journal of Clinical Investigation, 119(4), 700–705. http://dx.doi.org/10.1172/jci38832
Jensen, P. S., Arnold, L. E., Swanson, J. M., Vitiello B., Abikoff, H. B., Greenhill, L. L., … Hur, K. (2007). 3-year follow-up of the NIMH MTA study. Journal of the American Academy of Child & Adolescent Psychiatry, 46(8), 989–1002. http://dx.doi.org/10.1097/chi.0b013e3180686d48
Leins U., Goth G., Hinterberger T., Klinger, C., Rumpf, N., & Strehl, U. (2007). Neurofeedback for children with ADHD: A comparison of SCP and Theta/Beta protocols. Applied Psychophysiology and Biofeedback, 32, 73–88. http://dx.doi.org/10.1007/s10484-007-9031-0
Levesque, J., Beauregard, M., & Mensour, B. (2006). Effect of neurofeedback training on the neural substrates of selective attention in children with attention-deficit/hyperactivity disorder: A functional magnetic resonance imaging study. Neuroscience Letters, 394, 216–221. http://dx.doi.org/10.1016/j.neulet.2005.10.100
Lubar, J. F., & Shouse, M. N. (1976). EEG & behavioral changes in a hyperkinetic child concurrent with training of the sensorimotor rhythm (SMR): A preliminary report. Biofeedback & Self-Regulation, 3, 293–306. http://dx.doi.org/10.1007/bf01001170
Meisel, V., Servera, M., Garcia-Banda, G., Cardo, E., & Moreno, I. (2013). Neurofeedback and standard pharmacological intervention in ADHD: A randomized controlled trial with six-month follow-up. Biological Psychology, 94(1), 12–21. http://dx.doi.org/10.1016/j.biopsycho.2013.04.015
Monastra, V. J. (2005). Electroencephalographic biofeedback (neurotherapy) as a treatment for attention deficit hyperactivity disorder: Rationale and empirical foundation. Child and Adolescent Psychiatric Clinics of North America, 14, 55–82. http://dx.doi.org/10.1016/j.chc.2004.07.004
Monastra, V. J., Monastra, D. M., & George, S. (2002). The effects of stimulant therapy, EEG biofeedback, and parenting style on the primary symptoms of attention‐deficit/hyperactivity disorder. Applied Psychophysiology and Biofeedback, 27, 231–249.
MTA Cooperative Group. (1999). A 14-month randomized clinical trial of treatment strategies for attention-deficit/ hyperactivity disorder. Archives of General Psychiatry, 56(12), 1073–1086. http://dx.doi.org/10.1001/archpsyc.56.12.1073
MTA Cooperative Group. (2004a). National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics, 113, 754–761. http://dx.doi.org/10.1542/peds.113.4.754
MTA Cooperative Group. (2004b). National Institute of Mental Health multimodal treatment study of ADHD follow-up: Changes in effectiveness and growth after the end of treatment. Pediatrics, 113, 762–169. http://dx.doi.org/10.1542/peds.113.4.762
Molina, B. S., Hinshaw, S. P., Swanson, J. M., Arnold, L. E., Vitiello B., Jensen, P. S., … MTA Cooperative Group. (2009). The MTA at 8 years: Prospective follow-up of children treated for combined-type ADHD in a multisite study. Journal of the American Academy of Child & Adolescent Psychiatry, 48(5), 484–500. http://dx.doi.org/10.1097/chi.0b013e31819c23d0
NIMH website accessed March 1, 2014: http://www.nimh.nih.gov/science-news/2013/long-term-course-of-adhd-diagnosed-in-preschool-years-can-be-chronic-and-severe.shtml
Olfson, M., Blanco, C., Liu, S. M., Wang, S., & Correll, C. U. (2012). National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. Archives of General Psychiatry, 69(12), 1247–56. http://dx.doi.org/10.1001/archgenpsychiatry.2012.647
Olfson, M., Blanco, C., Wang, S., Laje, G., & Correll, C. U. (2014). National trends in the mental health care of children, adolescents, and adults by office-based physicians. JAMA Psychiatry, 71(1), 81–90. http://dx.doi.org/10.1001/jamapsychiatry.2013.3074
Pigott, H. E., Bodenhamer-Davis, E., Davis, R. E., & Harbin, H. (2013). Ending the evidentiary & insurance reimbursement bias against neurofeedback to treat ADHD: It will take clinician action in addition to the compelling science. Journal of Neurotherapy, 17, 93–105. http://dx.doi.org/10.1080/10874208.2013.785178
PracticeWise. (2012). Evidence-Based Child and Adolescent Psychosocial Interventions (see: http://www.aap.org/en-us/advocacy-and-policy/aap-health-initiatives/Mental-Health/Documents/CRPsychosocialinterventions.pdf).
Riddle, M., Yershova, K., Lazzaretto, D., Paykina, N., Yenokyan, G., Greenhill, L., … Posner, K. (2013). The preschool attention-deficit/hyperactivity disorder treatment study (PATS) 6-year follow-up. Journal of the American Academy of Child & Adolescent Psychiatry, 52(3), 264–278.
Rossiter, T. (2004). The effectiveness of neurofeedback and stimulant drugs in treating AD/HD: Part II. Replication. Applied Psychophysiological Biofeedback, 29(4), 233–243. http://dx.doi.org/10.1007/s10484-004-0383-4
Schwarz, A., & Cohen, S. (2013, March 31). A.D.H.D. seen in 11% of U.S. children as diagnoses rise. The New York Times. Retrieved from http://www.nytimes.com/2013/04/01/health/more-diagnoses-of-hyperactivity-causing-concern.html?nl=todaysheadlines&emc=edit_th_20130401&_r=1&
Schwarz, A. (2013, December 29). A.D.H.D. experts re-evaluate study’s zeal for drugs. The New York Times. Retrieved from http://www.nytimes.com/2013/12/30/health/adhd-experts-re-evaluate-studys-zeal-for-drugs.html?_r=0
Sherlin, L. H., Arns, M., Lubar, J., Heinrich, H., Kerson, C., Strehl, U., & Sterman, M. B. (2011). Neurofeedback and basic learning theory: Implications for research and practice. Journal of Neurotherapy, 15, 292–304. http://dx.doi.org/10.1080/10874208.2011.623089
Shouse, M. N. & Lubar, J. F. (1979). Operant conditioning of EEG rhythms and Ritalin in the treatment of hyperkinesis. Biofeedback & Self-Regulation, 4, 299-312. http://dx.doi.org/10.1007/bf00998960
Steiner, N. J., Frenette, E. C., Rene, K. M., Brennan, R. T., & Perrin, E. C. (2014a). Neurofeedback and cognitive attention training for children with Attention-Deficit Hyperactivity Disorder in schools. Journal of Developmental & Behavioral Pediatrics, 35, 18–27. http://dx.doi.org/10.1097/dbp.0000000000000009
Sonuga-Barke, E. J., Brandeis, D., Cortese, S., Daley, D., Ferrin, M., Holtmann, M., … & Sergeant, J. (2013). Nonpharmacological interventions for ADHD: Systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. American Journal of Psychiatry, 170(3), 275–289. http://dx.doi.org/10.1176/appi.ajp.2012.12070991
Steiner, N. J., Frenette, E. C., Rene, K. M., Brennan, R. T., & Perrin, E. C. (2014b). In-school neurofeedback training for ADHD: Sustained improvements from a randomized control trial. Pediatrics, 133, 483–492. http://dx.doi.org/10.1542/peds.2013-2059d
Strehl, U., Leins, U., Goth, G., Klinger, C., Hinterberger, T., & Birhaumer, N. (2006). Self-regulation of slow cortical potentials: A new treatment for children with attention-deficit/hyperactivity disorder. Pediatrics, 118, 1530–1540. http://dx.doi.org/10.1542/peds.2005-2478
Wangler, S., Gevensleben, H., Albrecht, B., Studer, P., Rothenberger, A., Moll, G. H., & Heinrich, H. (2011). Neurofeedback in children with ADHD: Specific event related potential findings of a randomized controlled trial. Clinical Neurophysiology, 122, 942–950. http://dx.doi.org/10.1016/j.clinph.2010.06.036
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).